2023/2239

9.11.2023

DECISION OF THE EEA JOINT COMMITTEE No 84/2023

of 28 April 2023

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2239]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2022/1484 of 7 September 2022 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2022/1486 of 7 September 2022 postponing the expiry date of the approval of acrolein for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2022/1487 of 7 September 2022 postponing the expiry date of the approval of etofenprox for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Decision (EU) 2022/1488 of 7 September 2022 postponing the expiry date of the approval of K-HDO for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Decision (EU) 2022/1489 of 7 September 2022 postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Decision (EU) 2022/1494 of 7 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Spray in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2022/1495 of 8 September 2022 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 7 ) is to be incorporated into the EEA Agreement.

(8) Commission Implementing Decision (EU) 2022/1496 of 8 September 2022 postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 8 ) is to be incorporated into the EEA Agreement.

(9) Commission Implementing Decision (EU) 2022/1497 of 8 September 2022 determining whether a product containing ‘ Capsicum oleoresin expeller pressed’ is a biocidal product, pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 9 ) is to be incorporated into the EEA Agreement.

(10) Commission Implementing Decision (EU) 2022/1515 of 8 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Junior Lotion in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 10 ) is to be incorporated into the EEA Agreement.

(11) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzzd (Commission Implementing Decision (EU) 2022/874) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzze.

32022 D 1484 : Commission Implementing Decision (EU) 2022/1484 of 7 September 2022 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 233, 8.9.2022, p. 79 ).

12zzzzzzzzf.

32022 D 1486 : Commission Implementing Decision (EU) 2022/1486 of 7 September 2022 postponing the expiry date of the approval of acrolein for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 233, 8.9.2022, p. 83 ).

12zzzzzzzzg.

32022 D 1487 : Commission Implementing Decision (EU) 2022/1487 of 7 September 2022 postponing the expiry date of the approval of etofenprox for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 233, 8.9.2022, p. 85 ).

12zzzzzzzzh.

32022 D 1488 : Commission Implementing Decision (EU) 2022/1488 of 7 September 2022 postponing the expiry date of the approval of K-HDO for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 233, 8.9.2022, p. 87 ).

12zzzzzzzzi.

32022 D 1489 : Commission Implementing Decision (EU) 2022/1489 of 7 September 2022 postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 233, 8.9.2022, p. 89 ).

12zzzzzzzzj.

32022 D 1494 : Commission Implementing Decision (EU) 2022/1494 of 7 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Spray in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 234, 9.9.2022, p. 23 ).

12zzzzzzzzk.

32022 D 1495 : Commission Implementing Decision (EU) 2022/1495 of 8 September 2022 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 234, 9.9.2022, p. 26 ).

12zzzzzzzzl.

32022 D 1496 : Commission Implementing Decision (EU) 2022/1496 of 8 September 2022 postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 234, 9.9.2022, p. 28 ).

12zzzzzzzzm.

32022 D 1497 : Commission Implementing Decision (EU) 2022/1497 of 8 September 2022 determining whether a product containing ‘ Capsicum oleoresin expeller pressed’ is a biocidal product, pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 234, 9.9.2022, p. 30 ).

12zzzzzzzzn.

32022 D 1515 : Commission Implementing Decision (EU) 2022/1515 of 8 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Junior Lotion in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 235, 12.9.2022, p. 58 ).’

Article 2

The texts of Implementing Decisions (EU) 2022/1484, (EU) 2022/1486, (EU) 2022/1487, (EU) 2022/1488, (EU) 2022/1489, (EU) 2022/1494, (EU) 2022/1495, (EU) 2022/1496, (EU) 2022/1497 and (EU) 2022/1515 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 28 April 2023.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 )    OJ L 233, 8.9.2022, p. 79 .

( 2 )    OJ L 233, 8.9.2022, p. 83 .

( 3 )    OJ L 233, 8.9.2022, p. 85 .

( 4 )    OJ L 233, 8.9.2022, p. 87 .

( 5 )    OJ L 233, 8.9.2022, p. 89 .

( 6 )    OJ L 234, 9.9.2022, p. 23 .

( 7 )    OJ L 234, 9.9.2022, p. 26 .

( 8 )    OJ L 234, 9.9.2022, p. 28 .

( 9 )    OJ L 234, 9.9.2022, p. 30 .

( 10 )    OJ L 235, 12.9.2022, p. 58 .

( *1 )   No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2023/2239/oj

ISSN 1977-0677 (electronic edition)